mRNA Vaccines and Therapeutics Market Report

China mRNA Vaccines and Therapeutics Industry Market Research Report 2023-2029

  • POSTDATE：Sep 21, 2023
  • PAGES：189
  • REPORT CODE：GMM1812538
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the mRNA Vaccines and Therapeutics industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • GlaxoSmithKline

    • Sangamo Therapeutics

    • Intellia Therapeutics

    • AstraZeneca Plc

    • Crispr Therapeutics

    • Bayer Group

    • Boehringer Ingelheim

    • Moderna

    • BioNtech

    By Type:

    • Individualized Cancer Treatment mRNA Vaccine

    • Infection Prevention mRNA Vaccine

    • Standardization Of Cancer Treatment mRNA Vaccine

    • Infectious Disease Treatment mRNA Vaccine

    By Application:

    • Hospital

    • Other

    • Clinic

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China mRNA Vaccines and Therapeutics Market Overview 2018-2029

    • 1.1 China mRNA Vaccines and Therapeutics Industry Development Overview

    • 1.2 China mRNA Vaccines and Therapeutics Industry Development History

    • 1.3 China mRNA Vaccines and Therapeutics Industry Market Size (2018-2029)

    • 1.4 China mRNA Vaccines and Therapeutics Market Analysis by Type from Production Side

      • 1.4.1 China mRNA Vaccines and Therapeutics Production Volume, Production Value and Growth Rate of Individualized Cancer Treatment mRNA Vaccine (2018-2029)

      • 1.4.2 China mRNA Vaccines and Therapeutics Production Volume, Production Value and Growth Rate of Infection Prevention mRNA Vaccine (2018-2029)

      • 1.4.3 China mRNA Vaccines and Therapeutics Production Volume, Production Value and Growth Rate of Standardization Of Cancer Treatment mRNA Vaccine (2018-2029)

      • 1.4.4 China mRNA Vaccines and Therapeutics Production Volume, Production Value and Growth Rate of Infectious Disease Treatment mRNA Vaccine (2018-2029)

    • 1.5 China mRNA Vaccines and Therapeutics Market Analysis by Application from Consumption End

      • 1.5.1 China mRNA Vaccines and Therapeutics Sales Volume, Sales Value and Growth Rate of Hospital (2018-2029)

      • 1.5.2 China mRNA Vaccines and Therapeutics Sales Volume, Sales Value and Growth Rate of Other (2018-2029)

      • 1.5.3 China mRNA Vaccines and Therapeutics Sales Volume, Sales Value and Growth Rate of Clinic (2018-2029)

    • 1.6 China mRNA Vaccines and Therapeutics Market Analysis by Region

      • 1.6.1 North China mRNA Vaccines and Therapeutics Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China mRNA Vaccines and Therapeutics Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China mRNA Vaccines and Therapeutics Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China mRNA Vaccines and Therapeutics Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China mRNA Vaccines and Therapeutics Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China mRNA Vaccines and Therapeutics Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China mRNA Vaccines and Therapeutics Market Size and Growth Rate from 2018-2029

    Chapter 2 China mRNA Vaccines and Therapeutics Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on mRNA Vaccines and Therapeutics Market Status and Competition at home and abroad in 2023

      • 2.2.2 China mRNA Vaccines and Therapeutics Market Status and Competition Analysis in 2023

      • 2.2.3 China mRNA Vaccines and Therapeutics Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China mRNA Vaccines and Therapeutics Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on mRNA Vaccines and Therapeutics Industry Development

    Chapter 3 mRNA Vaccines and TherapeuticsIndustry Chain Analysis

    • 3.1 mRNA Vaccines and Therapeutics Industry Chain

    • 3.2 mRNA Vaccines and Therapeutics Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the mRNA Vaccines and Therapeutics Market

    • 3.3 mRNA Vaccines and Therapeutics Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the mRNA Vaccines and Therapeutics Market

    Chapter 4 China mRNA Vaccines and Therapeutics Market, by Type

    • 4.1 China mRNA Vaccines and Therapeutics Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China mRNA Vaccines and Therapeutics Total Production Volume and Growth Rate from Production Side

    • 4.5 China mRNA Vaccines and Therapeutics Production Volume and Growth Rate, by Type

      • 4.5.1 China mRNA Vaccines and Therapeutics Production Volume and Growth Rate of Individualized Cancer Treatment mRNA Vaccine

      • 4.5.2 China mRNA Vaccines and Therapeutics Production Volume and Growth Rate of Infection Prevention mRNA Vaccine

      • 4.5.3 China mRNA Vaccines and Therapeutics Production Volume and Growth Rate of Standardization Of Cancer Treatment mRNA Vaccine

      • 4.5.4 China mRNA Vaccines and Therapeutics Production Volume and Growth Rate of Infectious Disease Treatment mRNA Vaccine

    Chapter 5 China mRNA Vaccines and Therapeutics Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China mRNA Vaccines and Therapeutics Total Market Size and Growth Rate from Consumption End

    • 5.5 China mRNA Vaccines and Therapeutics Market Size and Growth Rate, by Application

      • 5.5.1 China mRNA Vaccines and Therapeutics Market Size and Growth Rate of Hospital

      • 5.5.2 China mRNA Vaccines and Therapeutics Market Size and Growth Rate of Other

      • 5.5.3 China mRNA Vaccines and Therapeutics Market Size and Growth Rate of Clinic

    Chapter 6 China mRNA Vaccines and Therapeutics Market, by Region

    • 6.1 China mRNA Vaccines and Therapeutics Production Volume and Production Value, by Region

    • 6.2 China mRNA Vaccines and Therapeutics Sales Volume and Sales Value, by Region

    Chapter 7 North China mRNA Vaccines and Therapeutics Market Analysis

    • 7.1 North China mRNA Vaccines and Therapeutics Market, by Type

    • 7.2 North China mRNA Vaccines and Therapeutics Market, by Application

    Chapter 8 Central China mRNA Vaccines and Therapeutics Market Analysis

    • 8.1 Central China mRNA Vaccines and Therapeutics Market, by Type

    • 8.2 Central China mRNA Vaccines and Therapeutics Market, by Application

    Chapter 9 South China mRNA Vaccines and Therapeutics Market Analysis

    • 9.1 South China mRNA Vaccines and Therapeutics Market, by Type

    • 9.2 South China mRNA Vaccines and Therapeutics Market, by Application

    Chapter 10 East China mRNA Vaccines and Therapeutics Market Analysis

    • 10.1 East China mRNA Vaccines and Therapeutics Market, by Type

    • 10.2 East China mRNA Vaccines and Therapeutics Market, by Application

    Chapter 11 Northeast China mRNA Vaccines and Therapeutics Market Analysis

    • 11.1 Northeast China mRNA Vaccines and Therapeutics Market, by Type

    • 11.2 Northeast China mRNA Vaccines and Therapeutics Market, by Application

    Chapter 12 Southwest China mRNA Vaccines and Therapeutics Market Analysis

    • 12.1 Southwest China mRNA Vaccines and Therapeutics Market, by Type

    • 12.2 Southwest China mRNA Vaccines and Therapeutics Market, by Application

    Chapter 13 Northwest China mRNA Vaccines and Therapeutics Market Analysis

    • 13.1 Northwest China mRNA Vaccines and Therapeutics Market, by Type

    • 13.2 Northwest China mRNA Vaccines and Therapeutics Market, by Application

    Chapter 14 Company Profiles

      • 14.1 GlaxoSmithKline

        • 14.1.1 GlaxoSmithKline Company Profile

        • 14.1.2 GlaxoSmithKline mRNA Vaccines and Therapeutics Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Sangamo Therapeutics

        • 14.2.1 Sangamo Therapeutics Company Profile

        • 14.2.2 Sangamo Therapeutics mRNA Vaccines and Therapeutics Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Intellia Therapeutics

        • 14.3.1 Intellia Therapeutics Company Profile

        • 14.3.2 Intellia Therapeutics mRNA Vaccines and Therapeutics Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 AstraZeneca Plc

        • 14.4.1 AstraZeneca Plc Company Profile

        • 14.4.2 AstraZeneca Plc mRNA Vaccines and Therapeutics Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Crispr Therapeutics

        • 14.5.1 Crispr Therapeutics Company Profile

        • 14.5.2 Crispr Therapeutics mRNA Vaccines and Therapeutics Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Bayer Group

        • 14.6.1 Bayer Group Company Profile

        • 14.6.2 Bayer Group mRNA Vaccines and Therapeutics Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Boehringer Ingelheim

        • 14.7.1 Boehringer Ingelheim Company Profile

        • 14.7.2 Boehringer Ingelheim mRNA Vaccines and Therapeutics Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Moderna

        • 14.8.1 Moderna Company Profile

        • 14.8.2 Moderna mRNA Vaccines and Therapeutics Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 BioNtech

        • 14.9.1 BioNtech Company Profile

        • 14.9.2 BioNtech mRNA Vaccines and Therapeutics Market Performance

        • 14.9.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 mRNA Vaccines and Therapeutics Industry Research Conclusions

    • 15.2 mRNA Vaccines and Therapeutics Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China mRNA Vaccines and Therapeutics Industry Market Size (2018-2029)

    • Figure China mRNA Vaccines and Therapeutics Production Volume, Production Value and Growth Rate of Individualized Cancer Treatment mRNA Vaccine (2018-2029)

    • Figure China mRNA Vaccines and Therapeutics Production Volume, Production Value and Growth Rate of Infection Prevention mRNA Vaccine (2018-2029)

    • Figure China mRNA Vaccines and Therapeutics Production Volume, Production Value and Growth Rate of Standardization Of Cancer Treatment mRNA Vaccine (2018-2029)

    • Figure China mRNA Vaccines and Therapeutics Production Volume, Production Value and Growth Rate of Infectious Disease Treatment mRNA Vaccine (2018-2029)

    • Figure China mRNA Vaccines and Therapeutics Sales Volume, Sales Value and Growth Rate of Hospital (2018-2029)

    • Figure China mRNA Vaccines and Therapeutics Sales Volume, Sales Value and Growth Rate of Other (2018-2029)

    • Figure China mRNA Vaccines and Therapeutics Sales Volume, Sales Value and Growth Rate of Clinic (2018-2029)

    • Figure North China mRNA Vaccines and Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure Central China mRNA Vaccines and Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure South China mRNA Vaccines and Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure East China mRNA Vaccines and Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure Northeast China mRNA Vaccines and Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure Southwest China mRNA Vaccines and Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure Northwest China mRNA Vaccines and Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure mRNA Vaccines and Therapeutics Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China mRNA Vaccines and Therapeutics Market Share by Type in 2018

    • Figure China mRNA Vaccines and Therapeutics Market Share by Type in 2023

    • Figure China mRNA Vaccines and Therapeutics Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China mRNA Vaccines and Therapeutics Production Volume and Growth Rate of Individualized Cancer Treatment mRNA Vaccine (2018-2023)

    • Figure China mRNA Vaccines and Therapeutics Production Volume and Growth Rate of Infection Prevention mRNA Vaccine (2018-2023)

    • Figure China mRNA Vaccines and Therapeutics Production Volume and Growth Rate of Standardization Of Cancer Treatment mRNA Vaccine (2018-2023)

    • Figure China mRNA Vaccines and Therapeutics Production Volume and Growth Rate of Infectious Disease Treatment mRNA Vaccine (2018-2023)

    • Figure China mRNA Vaccines and Therapeutics Market Share by Application in 2018

    • Figure China mRNA Vaccines and Therapeutics Market Share by Application in 2023

    • Figure China mRNA Vaccines and Therapeutics Total Market Size and Growth Rate from Consumption End

    • Figure China mRNA Vaccines and Therapeutics Market Size and Growth Rate of Hospital (2018-2023)

    • Figure China mRNA Vaccines and Therapeutics Market Size and Growth Rate of Other (2018-2023)

    • Figure China mRNA Vaccines and Therapeutics Market Size and Growth Rate of Clinic (2018-2023)

    • Table China mRNA Vaccines and Therapeutics Production Volume by Region (2018-2023)

    • Table China mRNA Vaccines and Therapeutics Production Volume Share by Region (2018-2023)

    • Figure China mRNA Vaccines and Therapeutics Production Volume Share by Region (2018-2023)

    • Table China mRNA Vaccines and Therapeutics Production Value by Region (2018-2023)

    • Table China mRNA Vaccines and Therapeutics Production Value Share by Region (2018-2023)

    • Figure China mRNA Vaccines and Therapeutics Production Value Share by Region (2018-2023)

    • Table China mRNA Vaccines and Therapeutics Sales Volume by Region (2018-2023)

    • Table China mRNA Vaccines and Therapeutics Sales Volume Share by Region (2018-2023)

    • Figure China mRNA Vaccines and Therapeutics Sales Volume Share by Region (2018-2023)

    • Table China mRNA Vaccines and Therapeutics Sales Value by Region (2018-2023)

    • Table China mRNA Vaccines and Therapeutics Sales Value Share by Region (2018-2023)

    • Figure China mRNA Vaccines and Therapeutics Sales Value Share by Region (2018-2023)

    • Table North China mRNA Vaccines and Therapeutics Production Volume by Type (2018-2023)

    • Table North China mRNA Vaccines and Therapeutics Production Volume Share by Type (2018-2023)

    • Figure North China mRNA Vaccines and Therapeutics Production Volume Share by Type (2018-2023)

    • Table North China mRNA Vaccines and Therapeutics Sales Volume by Application (2018-2023)

    • Table North China mRNA Vaccines and Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure North China mRNA Vaccines and Therapeutics Sales Volume Share by Application (2018-2023)

    • Table Central China mRNA Vaccines and Therapeutics Production Volume by Type (2018-2023)

    • Table Central China mRNA Vaccines and Therapeutics Production Volume Share by Type (2018-2023)

    • Figure Central China mRNA Vaccines and Therapeutics Production Volume Share by Type (2018-2023)

    • Table Central China mRNA Vaccines and Therapeutics Sales Volume by Application (2018-2023)

    • Table Central China mRNA Vaccines and Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure Central China mRNA Vaccines and Therapeutics Sales Volume Share by Application (2018-2023)

    • Table South China mRNA Vaccines and Therapeutics Production Volume by Type (2018-2023)

    • Table South China mRNA Vaccines and Therapeutics Production Volume Share by Type (2018-2023)

    • Figure South China mRNA Vaccines and Therapeutics Production Volume Share by Type (2018-2023)

    • Table South China mRNA Vaccines and Therapeutics Sales Volume by Application (2018-2023)

    • Table South China mRNA Vaccines and Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure South China mRNA Vaccines and Therapeutics Sales Volume Share by Application (2018-2023)

    • Table East China mRNA Vaccines and Therapeutics Production Volume by Type (2018-2023)

    • Table East China mRNA Vaccines and Therapeutics Production Volume Share by Type (2018-2023)

    • Figure East China mRNA Vaccines and Therapeutics Production Volume Share by Type (2018-2023)

    • Table East China mRNA Vaccines and Therapeutics Sales Volume by Application (2018-2023)

    • Table East China mRNA Vaccines and Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure East China mRNA Vaccines and Therapeutics Sales Volume Share by Application (2018-2023)

    • Table Northeast China mRNA Vaccines and Therapeutics Production Volume by Type (2018-2023)

    • Table Northeast China mRNA Vaccines and Therapeutics Production Volume Share by Type (2018-2023)

    • Figure Northeast China mRNA Vaccines and Therapeutics Production Volume Share by Type (2018-2023)

    • Table Northeast China mRNA Vaccines and Therapeutics Sales Volume by Application (2018-2023)

    • Table Northeast China mRNA Vaccines and Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure Northeast China mRNA Vaccines and Therapeutics Sales Volume Share by Application (2018-2023)

    • Table Southwest China mRNA Vaccines and Therapeutics Production Volume by Type (2018-2023)

    • Table Southwest China mRNA Vaccines and Therapeutics Production Volume Share by Type (2018-2023)

    • Figure Southwest China mRNA Vaccines and Therapeutics Production Volume Share by Type (2018-2023)

    • Table Southwest China mRNA Vaccines and Therapeutics Sales Volume by Application (2018-2023)

    • Table Southwest China mRNA Vaccines and Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure Southwest China mRNA Vaccines and Therapeutics Sales Volume Share by Application (2018-2023)

    • Table Northwest China mRNA Vaccines and Therapeutics Production Volume by Type (2018-2023)

    • Table Northwest China mRNA Vaccines and Therapeutics Production Volume Share by Type (2018-2023)

    • Figure Northwest China mRNA Vaccines and Therapeutics Production Volume Share by Type (2018-2023)

    • Table Northwest China mRNA Vaccines and Therapeutics Sales Volume by Application (2018-2023)

    • Table Northwest China mRNA Vaccines and Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure Northwest China mRNA Vaccines and Therapeutics Sales Volume Share by Application (2018-2023)

    • Table GlaxoSmithKline Company Profile

    • Table GlaxoSmithKline mRNA Vaccines and Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Sangamo Therapeutics Company Profile

    • Table Sangamo Therapeutics mRNA Vaccines and Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Intellia Therapeutics Company Profile

    • Table Intellia Therapeutics mRNA Vaccines and Therapeutics Revenue, Price and Gross (2018-2023)

    • Table AstraZeneca Plc Company Profile

    • Table AstraZeneca Plc mRNA Vaccines and Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Crispr Therapeutics Company Profile

    • Table Crispr Therapeutics mRNA Vaccines and Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Bayer Group Company Profile

    • Table Bayer Group mRNA Vaccines and Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Boehringer Ingelheim Company Profile

    • Table Boehringer Ingelheim mRNA Vaccines and Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Moderna Company Profile

    • Table Moderna mRNA Vaccines and Therapeutics Revenue, Price and Gross (2018-2023)

    • Table BioNtech Company Profile

    • Table BioNtech mRNA Vaccines and Therapeutics Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US